VistaPharm, Inc. recalls Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
Failed Stability Specifications
Read the official notice →- Date
- 2022-01-26
- Country
- United States
- Brand
- VistaPharm
- Product
- Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
- Classification
- Class II
- Units
- Nationwide within the United States including Puerto Rico
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More VistaPharm recalls
- 2023-12-06
USVistaPharm LLC recalls Aminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz. (236.5 mL) HDPE bottles, Manufactured for: VistaPharm,…
Failed Excipient Specifications: high content of ethylene glycol (EG)
- 2023-11-15
- US
VistaPharm LLC recalls Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA,…
Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.
- 2023-10-25
- US
VistaPharm LLC recalls Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by:…
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
- 2023-09-20
- US
VistaPharm LLC recalls Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by:…
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
- 2022-11-02
- US
VistaPharm, Inc. recalls Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC…
cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
Other drugs & medical recalls in the United States
- 2022-01-26
- US
Mayne Pharma Inc recalls Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC…
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
- US
- US
Lohxa, LLC recalls SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.
Microbial Contamination of Non-Sterile Product
FDA · DrugLohxa, LLCProduct was distributed to one wholesale who further distributed the product…Official notice → - US
- US
Teva Pharmaceuticals USA recalls Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottles (NDC 0591-2127-79), and b) 15 ml dropper bottles (NDC…
Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.
- US
Geri-Care Pharmaceuticals Recalls Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child…